

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of sodium ion transport (GO:0010766) | 9.64561378 |
| 2 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 8.78675716 |
| 3 | protein polyglutamylation (GO:0018095) | 8.57972896 |
| 4 | estrogen biosynthetic process (GO:0006703) | 8.30755578 |
| 5 | regulation of tight junction assembly (GO:2000810) | 7.64704251 |
| 6 | toxin transport (GO:1901998) | 7.21958454 |
| 7 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 7.01620571 |
| 8 | negative regulation of systemic arterial blood pressure (GO:0003085) | 6.84870520 |
| 9 | pyrimidine nucleotide catabolic process (GO:0006244) | 6.55366041 |
| 10 | definitive hemopoiesis (GO:0060216) | 6.28483615 |
| 11 | oligosaccharide biosynthetic process (GO:0009312) | 6.04111382 |
| 12 | base-excision repair, AP site formation (GO:0006285) | 5.92159835 |
| 13 | axoneme assembly (GO:0035082) | 5.77522125 |
| 14 | androgen biosynthetic process (GO:0006702) | 5.67599008 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 5.58006336 |
| 16 | epithelial cell differentiation involved in kidney development (GO:0035850) | 5.43270726 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.02831096 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.83220043 |
| 19 | response to salt stress (GO:0009651) | 4.80611027 |
| 20 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 4.67528644 |
| 21 | aggressive behavior (GO:0002118) | 4.53738743 |
| 22 | barbed-end actin filament capping (GO:0051016) | 4.44677712 |
| 23 | negative regulation of potassium ion transport (GO:0043267) | 4.41194287 |
| 24 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.38862647 |
| 25 | response to oxygen radical (GO:0000305) | 4.36714710 |
| 26 | hemoglobin metabolic process (GO:0020027) | 4.32260664 |
| 27 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.25975412 |
| 28 | drug transport (GO:0015893) | 4.23796784 |
| 29 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.10911920 |
| 30 | GPI anchor biosynthetic process (GO:0006506) | 3.93132189 |
| 31 | regulation of B cell differentiation (GO:0045577) | 3.88105504 |
| 32 | positive regulation of cation channel activity (GO:2001259) | 3.85069008 |
| 33 | regulation of female receptivity (GO:0045924) | 3.83433685 |
| 34 | regulation of chromatin binding (GO:0035561) | 3.82710678 |
| 35 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.72598542 |
| 36 | eye photoreceptor cell differentiation (GO:0001754) | 3.69291362 |
| 37 | photoreceptor cell differentiation (GO:0046530) | 3.69291362 |
| 38 | estrogen metabolic process (GO:0008210) | 3.64277485 |
| 39 | ketone biosynthetic process (GO:0042181) | 3.58256374 |
| 40 | thrombin receptor signaling pathway (GO:0070493) | 3.57822151 |
| 41 | polyamine biosynthetic process (GO:0006596) | 3.52426932 |
| 42 | GPI anchor metabolic process (GO:0006505) | 3.46509859 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40733324 |
| 44 | cardiolipin metabolic process (GO:0032048) | 3.34363843 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.34099015 |
| 46 | pentose-phosphate shunt (GO:0006098) | 3.33876029 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.29149188 |
| 48 | female mating behavior (GO:0060180) | 3.27111829 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.25104645 |
| 50 | endothelium development (GO:0003158) | 3.25064596 |
| 51 | negative regulation of granulocyte differentiation (GO:0030853) | 3.22446415 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20799329 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18997679 |
| 54 | polyketide metabolic process (GO:0030638) | 3.18740311 |
| 55 | doxorubicin metabolic process (GO:0044598) | 3.18740311 |
| 56 | daunorubicin metabolic process (GO:0044597) | 3.18740311 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 3.18232035 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17887826 |
| 59 | zinc ion homeostasis (GO:0055069) | 3.17821791 |
| 60 | deoxyribonucleotide catabolic process (GO:0009264) | 3.10845368 |
| 61 | DNA damage response, detection of DNA damage (GO:0042769) | 3.07409125 |
| 62 | DNA demethylation (GO:0080111) | 3.03708168 |
| 63 | Peyers patch development (GO:0048541) | 2.97991101 |
| 64 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.97991101 |
| 65 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.94983870 |
| 66 | cell volume homeostasis (GO:0006884) | 2.92165143 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91450320 |
| 68 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91110863 |
| 69 | valine metabolic process (GO:0006573) | 2.91048397 |
| 70 | ribosomal small subunit assembly (GO:0000028) | 2.89619886 |
| 71 | branched-chain amino acid metabolic process (GO:0009081) | 2.88988778 |
| 72 | ribonucleoprotein complex disassembly (GO:0032988) | 2.87690963 |
| 73 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.84288217 |
| 74 | NADPH regeneration (GO:0006740) | 2.82972851 |
| 75 | angiogenesis involved in wound healing (GO:0060055) | 2.81926978 |
| 76 | megakaryocyte development (GO:0035855) | 2.80064557 |
| 77 | deoxyribose phosphate catabolic process (GO:0046386) | 2.80042702 |
| 78 | positive regulation of activated T cell proliferation (GO:0042104) | 2.79302712 |
| 79 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.78861176 |
| 80 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.78861176 |
| 81 | negative thymic T cell selection (GO:0045060) | 2.77533070 |
| 82 | positive regulation of histone deacetylation (GO:0031065) | 2.77326458 |
| 83 | GTP biosynthetic process (GO:0006183) | 2.76771440 |
| 84 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.75151441 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74273334 |
| 86 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.73342893 |
| 87 | peptidyl-histidine modification (GO:0018202) | 2.72247412 |
| 88 | androgen metabolic process (GO:0008209) | 2.71404241 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71152436 |
| 90 | protein localization to cell surface (GO:0034394) | 2.68578362 |
| 91 | DNA dealkylation (GO:0035510) | 2.68310139 |
| 92 | negative T cell selection (GO:0043383) | 2.66732277 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.62644301 |
| 94 | actin nucleation (GO:0045010) | 2.62052441 |
| 95 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60039411 |
| 96 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.57224578 |
| 97 | peptidyl-glutamic acid modification (GO:0018200) | 2.56955681 |
| 98 | response to peptidoglycan (GO:0032494) | 2.55904009 |
| 99 | glucose catabolic process (GO:0006007) | 2.55515784 |
| 100 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 10.0284622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.54085877 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 5.66180753 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.74826343 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.18897639 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87857453 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79332151 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20281774 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.92144256 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39262289 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34332924 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23277486 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08014463 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 11.0338889 |
| 14 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.98836146 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.91552941 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 1.86752496 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84239358 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80804013 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78488117 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74313106 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72106492 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70531441 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60127883 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58553361 |
| 25 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57279149 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55979229 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52518346 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50162553 |
| 29 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47372756 |
| 30 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44286204 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44187610 |
| 32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43799189 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42064118 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40116542 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34057588 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34015342 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33364648 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.30319396 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28963274 |
| 40 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.24600901 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24346561 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23479048 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23109760 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.18571987 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17537688 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16931141 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15127430 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13504128 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13018344 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08440261 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07443425 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06242133 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03767540 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99416596 |
| 55 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99171218 |
| 56 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98696052 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98523334 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98140305 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96807573 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96554850 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 0.94800923 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93705320 |
| 63 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92791380 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92494455 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90297223 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89797745 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88447143 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.87915274 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87237595 |
| 70 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86511808 |
| 71 | P300_27268052_Chip-Seq_Bcells_Human | 0.86351846 |
| 72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83930583 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81795251 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81424154 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79524996 |
| 76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78909239 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77381545 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77259869 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77046713 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.76597840 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75884234 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75849044 |
| 83 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73847270 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.73080091 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 0.71607336 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.71242005 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71219071 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69918479 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69228126 |
| 90 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.68939818 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.68542221 |
| 92 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.67626481 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67217629 |
| 94 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67133780 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65424535 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.65360544 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.64456417 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64126033 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.63241954 |
| 100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.63052701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000465_gastrointestinal_hemorrhage | 6.49543734 |
| 2 | MP0003567_abnormal_fetal_cardiomyocyte | 3.15296041 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 2.88991432 |
| 4 | MP0005646_abnormal_pituitary_gland | 2.80941188 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.73917373 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.73917373 |
| 7 | MP0003075_altered_response_to | 2.56320676 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.56244527 |
| 9 | MP0003787_abnormal_imprinting | 2.53083303 |
| 10 | MP0005451_abnormal_body_composition | 2.51321675 |
| 11 | MP0002009_preneoplasia | 2.44619587 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.42695611 |
| 13 | MP0003436_decreased_susceptibility_to | 2.37857182 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.31416876 |
| 15 | MP0001664_abnormal_digestion | 2.23429220 |
| 16 | MP0001800_abnormal_humoral_immune | 2.20464996 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.18619199 |
| 18 | MP0009278_abnormal_bone_marrow | 2.12116364 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.11652660 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.98804879 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 1.97227926 |
| 22 | MP0000681_abnormal_thyroid_gland | 1.92954480 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.89399387 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87392894 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.87205086 |
| 26 | MP0002398_abnormal_bone_marrow | 1.87031887 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.76076340 |
| 28 | MP0002723_abnormal_immune_serum | 1.70756640 |
| 29 | MP0001790_abnormal_immune_system | 1.69649256 |
| 30 | MP0005387_immune_system_phenotype | 1.69649256 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.66476124 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.66358319 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.66357226 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.64815790 |
| 35 | MP0001819_abnormal_immune_cell | 1.62356755 |
| 36 | MP0004233_abnormal_muscle_weight | 1.56736656 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.56640140 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.56441972 |
| 39 | MP0000716_abnormal_immune_system | 1.53873943 |
| 40 | MP0003718_maternal_effect | 1.52920435 |
| 41 | MP0001905_abnormal_dopamine_level | 1.48290008 |
| 42 | MP0003724_increased_susceptibility_to | 1.46764352 |
| 43 | MP0005166_decreased_susceptibility_to | 1.44315398 |
| 44 | MP0000428_abnormal_craniofacial_morphol | 1.40562012 |
| 45 | MP0000733_abnormal_muscle_development | 1.40115965 |
| 46 | MP0005025_abnormal_response_to | 1.38538429 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.33859246 |
| 48 | MP0008469_abnormal_protein_level | 1.33682024 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.33570226 |
| 50 | MP0002429_abnormal_blood_cell | 1.31329657 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.30146626 |
| 52 | MP0002419_abnormal_innate_immunity | 1.26374518 |
| 53 | MP0002006_tumorigenesis | 1.25159639 |
| 54 | MP0006292_abnormal_olfactory_placode | 1.22790687 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.22514441 |
| 56 | MP0002722_abnormal_immune_system | 1.20652009 |
| 57 | MP0009785_altered_susceptibility_to | 1.16996336 |
| 58 | MP0003959_abnormal_lean_body | 1.12739151 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.10633451 |
| 60 | MP0001881_abnormal_mammary_gland | 1.08850706 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.08324261 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.05906699 |
| 63 | MP0003186_abnormal_redox_activity | 1.03439734 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.02258420 |
| 65 | MP0002160_abnormal_reproductive_system | 0.98687568 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.98183167 |
| 67 | MP0000516_abnormal_urinary_system | 0.97386584 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 0.97386584 |
| 69 | MP0003690_abnormal_glial_cell | 0.95011321 |
| 70 | MP0004147_increased_porphyrin_level | 0.94763912 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93636656 |
| 72 | MP0009384_cardiac_valve_regurgitation | 0.91928575 |
| 73 | MP0005671_abnormal_response_to | 0.91515551 |
| 74 | MP0001533_abnormal_skeleton_physiology | 0.91459816 |
| 75 | MP0002234_abnormal_pharynx_morphology | 0.90003386 |
| 76 | MP0001764_abnormal_homeostasis | 0.89678738 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.89233600 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.85622820 |
| 79 | MP0001324_abnormal_eye_pigmentation | 0.83981887 |
| 80 | MP0001845_abnormal_inflammatory_respons | 0.82516338 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.82296477 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.79333777 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.79153861 |
| 84 | MP0003303_peritoneal_inflammation | 0.77060608 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.76974819 |
| 86 | MP0005390_skeleton_phenotype | 0.74356156 |
| 87 | MP0009764_decreased_sensitivity_to | 0.74303858 |
| 88 | MP0003122_maternal_imprinting | 0.71663825 |
| 89 | MP0000685_abnormal_immune_system | 0.70701160 |
| 90 | MP0005385_cardiovascular_system_phenoty | 0.68720707 |
| 91 | MP0001544_abnormal_cardiovascular_syste | 0.68720707 |
| 92 | MP0001851_eye_inflammation | 0.65622820 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.65171269 |
| 94 | MP0003795_abnormal_bone_structure | 0.65037439 |
| 95 | MP0008872_abnormal_physiological_respon | 0.64751952 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.64403580 |
| 97 | MP0005535_abnormal_body_temperature | 0.64035136 |
| 98 | MP0005165_increased_susceptibility_to | 0.63412336 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.62799583 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.62697162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 8.63040097 |
| 2 | Facial hemangioma (HP:0000329) | 7.18079819 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 6.79528966 |
| 4 | Abnormality of the lumbar spine (HP:0100712) | 6.57700232 |
| 5 | Thoracolumbar scoliosis (HP:0002944) | 6.46450033 |
| 6 | Thoracic kyphosis (HP:0002942) | 6.12791835 |
| 7 | Abnormality of the columella (HP:0009929) | 4.99968688 |
| 8 | Self-mutilation (HP:0000742) | 4.90818103 |
| 9 | Abnormality of the intrinsic pathway (HP:0010989) | 4.78177675 |
| 10 | Dyschromatopsia (HP:0007641) | 4.78144907 |
| 11 | Capillary hemangiomas (HP:0005306) | 4.73943105 |
| 12 | Agammaglobulinemia (HP:0004432) | 4.50694803 |
| 13 | Protruding tongue (HP:0010808) | 4.21913409 |
| 14 | Central scotoma (HP:0000603) | 4.16340002 |
| 15 | Abnormality of the thoracic spine (HP:0100711) | 4.05082282 |
| 16 | Decreased central vision (HP:0007663) | 3.99580900 |
| 17 | Cellulitis (HP:0100658) | 3.92838863 |
| 18 | Generalized hypotonia (HP:0001290) | 3.77702761 |
| 19 | Abnormal protein glycosylation (HP:0012346) | 3.72518829 |
| 20 | Abnormal glycosylation (HP:0012345) | 3.72518829 |
| 21 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.72518829 |
| 22 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.72518829 |
| 23 | Alopecia of scalp (HP:0002293) | 3.61692868 |
| 24 | Syringomyelia (HP:0003396) | 3.46871343 |
| 25 | Spinal cord lesions (HP:0100561) | 3.46871343 |
| 26 | Coxa valga (HP:0002673) | 3.43389251 |
| 27 | Macular degeneration (HP:0000608) | 3.37300543 |
| 28 | Cone-rod dystrophy (HP:0000548) | 3.30438828 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.29762600 |
| 30 | Obstructive lung disease (HP:0006536) | 3.21590341 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21590341 |
| 32 | Hyperthyroidism (HP:0000836) | 3.17701716 |
| 33 | Long eyelashes (HP:0000527) | 3.08758883 |
| 34 | Pustule (HP:0200039) | 3.07762125 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.98936786 |
| 36 | Unsteady gait (HP:0002317) | 2.95087511 |
| 37 | Peritonitis (HP:0002586) | 2.88253669 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.80899807 |
| 39 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.79069325 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.71829865 |
| 41 | Microretrognathia (HP:0000308) | 2.65098544 |
| 42 | Abnormality of the peritoneum (HP:0002585) | 2.52554789 |
| 43 | Seborrheic dermatitis (HP:0001051) | 2.41440360 |
| 44 | Slender long bone (HP:0003100) | 2.39418185 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.39274541 |
| 46 | Thrombocytosis (HP:0001894) | 2.39100086 |
| 47 | Hypertensive crisis (HP:0100735) | 2.39089711 |
| 48 | Abolished electroretinogram (ERG) (HP:0000550) | 2.37755604 |
| 49 | Severe visual impairment (HP:0001141) | 2.36243365 |
| 50 | Chest pain (HP:0100749) | 2.35616291 |
| 51 | Meningitis (HP:0001287) | 2.30694576 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30478151 |
| 53 | Proximal placement of thumb (HP:0009623) | 2.28580735 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.25655305 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.25585603 |
| 56 | Spontaneous abortion (HP:0005268) | 2.23507233 |
| 57 | Recurrent pneumonia (HP:0006532) | 2.22749371 |
| 58 | Chronic sinusitis (HP:0011109) | 2.19064346 |
| 59 | Scotoma (HP:0000575) | 2.18198190 |
| 60 | Rib fusion (HP:0000902) | 2.15896988 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.14389312 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.12364056 |
| 63 | Aplastic anemia (HP:0001915) | 2.12250194 |
| 64 | Congenital stationary night blindness (HP:0007642) | 2.09886834 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.08427414 |
| 66 | Metaphyseal dysplasia (HP:0100255) | 2.06862243 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.02620312 |
| 68 | Cheilitis (HP:0100825) | 2.01349177 |
| 69 | Short middle phalanx of the 5th finger (HP:0004220) | 1.99540358 |
| 70 | Epistaxis (HP:0000421) | 1.96402552 |
| 71 | Gingival bleeding (HP:0000225) | 1.94818952 |
| 72 | Amaurosis fugax (HP:0100576) | 1.92646902 |
| 73 | Deviation of the thumb (HP:0009603) | 1.92435740 |
| 74 | Verrucae (HP:0200043) | 1.89663161 |
| 75 | Papilloma (HP:0012740) | 1.89663161 |
| 76 | Ulnar claw (HP:0001178) | 1.89588694 |
| 77 | Congenital primary aphakia (HP:0007707) | 1.87211295 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86676644 |
| 79 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.85221233 |
| 80 | Beaking of vertebral bodies (HP:0004568) | 1.84839815 |
| 81 | Gait imbalance (HP:0002141) | 1.81298876 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81082239 |
| 83 | Abnormality of macrophages (HP:0004311) | 1.80485985 |
| 84 | Osteomyelitis (HP:0002754) | 1.78688287 |
| 85 | Truncus arteriosus (HP:0001660) | 1.75480157 |
| 86 | Recurrent viral infections (HP:0004429) | 1.74648662 |
| 87 | Neonatal respiratory distress (HP:0002643) | 1.74023030 |
| 88 | Increased IgM level (HP:0003496) | 1.73281012 |
| 89 | Inflammation of the large intestine (HP:0002037) | 1.73259336 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.71876961 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71120530 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.70600887 |
| 93 | Supernumerary ribs (HP:0005815) | 1.68186411 |
| 94 | Short clavicles (HP:0000894) | 1.67209818 |
| 95 | Overlapping toe (HP:0001845) | 1.66512228 |
| 96 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.65291140 |
| 97 | Abnormality of T cells (HP:0002843) | 1.64573007 |
| 98 | Alveolar cell carcinoma (HP:0006519) | 1.63419703 |
| 99 | Microvesicular hepatic steatosis (HP:0001414) | 1.63026514 |
| 100 | Vasculitis (HP:0002633) | 1.62327859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DAPK2 | 5.70235123 |
| 2 | DAPK1 | 3.55595396 |
| 3 | MAP4K1 | 3.19828251 |
| 4 | ERN1 | 2.97511783 |
| 5 | TXK | 2.95404329 |
| 6 | TAF1 | 2.91579162 |
| 7 | IRAK4 | 2.82285095 |
| 8 | VRK2 | 2.70347566 |
| 9 | DAPK3 | 2.57597717 |
| 10 | TAOK3 | 2.36167492 |
| 11 | TNIK | 2.26764317 |
| 12 | GRK6 | 2.26281612 |
| 13 | SMG1 | 2.19697073 |
| 14 | NUAK1 | 2.16127116 |
| 15 | BCKDK | 2.09484180 |
| 16 | TIE1 | 1.92685800 |
| 17 | TBK1 | 1.80220731 |
| 18 | JAK3 | 1.75498725 |
| 19 | TESK2 | 1.64502590 |
| 20 | RPS6KC1 | 1.63113285 |
| 21 | RPS6KL1 | 1.63113285 |
| 22 | KIT | 1.61701793 |
| 23 | RPS6KA6 | 1.51783742 |
| 24 | PRKG2 | 1.51644309 |
| 25 | KDR | 1.49419943 |
| 26 | HIPK2 | 1.44335082 |
| 27 | TYK2 | 1.39750032 |
| 28 | MAPKAPK5 | 1.39393775 |
| 29 | SYK | 1.28576927 |
| 30 | ZAP70 | 1.25151948 |
| 31 | RPS6KA2 | 1.17810422 |
| 32 | MAP3K4 | 1.08732236 |
| 33 | CDK6 | 1.03831654 |
| 34 | ROCK2 | 0.99301678 |
| 35 | CDK19 | 0.96769693 |
| 36 | BMPR2 | 0.95967577 |
| 37 | NEK2 | 0.90500176 |
| 38 | VRK1 | 0.90393011 |
| 39 | ILK | 0.89729701 |
| 40 | MAPK10 | 0.89280335 |
| 41 | PINK1 | 0.88547312 |
| 42 | TNK2 | 0.88510132 |
| 43 | IKBKB | 0.85575085 |
| 44 | STK4 | 0.85330864 |
| 45 | BTK | 0.84815217 |
| 46 | NME2 | 0.84535431 |
| 47 | BRAF | 0.84046186 |
| 48 | LYN | 0.81795804 |
| 49 | FLT3 | 0.81185689 |
| 50 | TEC | 0.80759200 |
| 51 | PRPF4B | 0.80281583 |
| 52 | HCK | 0.79740637 |
| 53 | JAK2 | 0.79055473 |
| 54 | IKBKE | 0.77293768 |
| 55 | MARK3 | 0.75778660 |
| 56 | MATK | 0.73472596 |
| 57 | PIM2 | 0.73333507 |
| 58 | PRKCD | 0.73006638 |
| 59 | MAPK13 | 0.70977636 |
| 60 | PIM1 | 0.69192272 |
| 61 | FES | 0.68174606 |
| 62 | RPS6KA4 | 0.67106189 |
| 63 | PKN1 | 0.65778750 |
| 64 | LCK | 0.64227238 |
| 65 | MKNK1 | 0.64071320 |
| 66 | BLK | 0.63356996 |
| 67 | MAPK15 | 0.63143818 |
| 68 | NLK | 0.62987871 |
| 69 | ITK | 0.62505201 |
| 70 | LATS1 | 0.62281729 |
| 71 | GRK5 | 0.59786205 |
| 72 | MAPK11 | 0.58471160 |
| 73 | CSF1R | 0.56435468 |
| 74 | MAP3K14 | 0.55949107 |
| 75 | PLK4 | 0.55247638 |
| 76 | CDC7 | 0.53425284 |
| 77 | FYN | 0.53006071 |
| 78 | PRKCQ | 0.52452065 |
| 79 | PBK | 0.49314285 |
| 80 | MAP2K2 | 0.46523785 |
| 81 | MAPK3 | 0.46406138 |
| 82 | CAMKK1 | 0.46191727 |
| 83 | UHMK1 | 0.44627061 |
| 84 | RPS6KA1 | 0.44362233 |
| 85 | CDK9 | 0.44356726 |
| 86 | ABL2 | 0.44330608 |
| 87 | CSNK1G3 | 0.40029739 |
| 88 | MAPKAPK2 | 0.39702882 |
| 89 | RIPK4 | 0.37336360 |
| 90 | RPS6KA5 | 0.36990933 |
| 91 | PRKD2 | 0.35024301 |
| 92 | SIK2 | 0.34500359 |
| 93 | CDK7 | 0.33897103 |
| 94 | CCNB1 | 0.32762729 |
| 95 | MAP2K7 | 0.32344153 |
| 96 | MAP3K5 | 0.31039183 |
| 97 | IGF1R | 0.29072086 |
| 98 | IRAK2 | 0.28976383 |
| 99 | CDK14 | 0.28420706 |
| 100 | ATR | 0.28404587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.70044322 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.66226851 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.50097122 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.49841834 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.48327529 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.16278372 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.10156941 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69504915 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.58384792 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.49964990 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45635811 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35786641 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.28919840 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.26716356 |
| 15 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 2.06271595 |
| 16 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.04942668 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94604431 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.91543682 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.88883613 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87329238 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69744278 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69084679 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.68529995 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59595426 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58941162 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56929202 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51057291 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38932002 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36167467 |
| 30 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.31633986 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15456580 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.11406248 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08281299 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07113934 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05315718 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04289619 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00392832 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99418927 |
| 39 | Measles_Homo sapiens_hsa05162 | 0.98775001 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95251676 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 0.92658120 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86173269 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84906163 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83866859 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83454378 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82462889 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 0.82064412 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81281920 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80184143 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79284211 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70225914 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.66866412 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66353738 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.65330546 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64321873 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64250144 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60874152 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.56486658 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56167617 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54886413 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53853070 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51743186 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51566489 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50482178 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48656247 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48243109 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.47026157 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.45474099 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45071126 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44785249 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44382093 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41177851 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.39737616 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39512747 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39150084 |
| 76 | Melanoma_Homo sapiens_hsa05218 | 0.37890792 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37140156 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34772539 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.34564780 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.32814456 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32051359 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28068278 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28020391 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27800915 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27046801 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.25224256 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24360220 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23740468 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.22434847 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21639298 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21494066 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21348309 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21267032 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20676781 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20429029 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20375365 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.19648870 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18718420 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18463075 |
| 100 | Homologous recombination_Homo sapiens_hsa03440 | 0.17689381 |

